Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3UPR

HLA-B*57:01 complexed to pep-V and Abacavir

3UPR の概要
エントリーDOI10.2210/pdb3upr/pdb
関連するPDBエントリー2BVO 2BVP 2HJL 2RFX
分子名称HLA class I histocompatibility antigen, B-57 alpha chain, pep-V, Beta-2-microglobulin, ... (6 entities in total)
機能のキーワードhla-b*57:01, mhc, antigen presenting cell, t-cell receptor, human leukocyte antigen, drug hypersensitivity, abacavir hypersensitivity, repertoire-altering small molecule, immune response, immunoglobulin-like beta-sandwich, immune system
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Membrane; Single-pass type I membrane protein: P18465
Secreted: P61769
タンパク質・核酸の鎖数6
化学式量合計89961.09
構造登録者
Pompeu, Y.A.,Ostrov, D.A. (登録日: 2011-11-18, 公開日: 2012-06-13, 最終更新日: 2024-10-16)
主引用文献Ostrov, D.A.,Grant, B.J.,Pompeu, Y.A.,Sidney, J.,Harndahl, M.,Southwood, S.,Oseroff, C.,Lu, S.,Jakoncic, J.,de Oliveira, C.A.,Yang, L.,Mei, H.,Shi, L.,Shabanowitz, J.,English, A.M.,Wriston, A.,Lucas, A.,Phillips, E.,Mallal, S.,Grey, H.M.,Sette, A.,Hunt, D.F.,Buus, S.,Peters, B.
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
Proc.Natl.Acad.Sci.USA, 109:9959-9964, 2012
Cited by
PubMed Abstract: Idiosyncratic adverse drug reactions are unpredictable, dose-independent and potentially life threatening; this makes them a major factor contributing to the cost and uncertainty of drug development. Clinical data suggest that many such reactions involve immune mechanisms, and genetic association studies have identified strong linkages between drug hypersensitivity reactions to several drugs and specific HLA alleles. One of the strongest such genetic associations found has been for the antiviral drug abacavir, which causes severe adverse reactions exclusively in patients expressing the HLA molecular variant B*57:01. Abacavir adverse reactions were recently shown to be driven by drug-specific activation of cytokine-producing, cytotoxic CD8(+) T cells that required HLA-B*57:01 molecules for their function; however, the mechanism by which abacavir induces this pathologic T-cell response remains unclear. Here we show that abacavir can bind within the F pocket of the peptide-binding groove of HLA-B*57:01, thereby altering its specificity. This provides an explanation for HLA-linked idiosyncratic adverse drug reactions, namely that drugs can alter the repertoire of self-peptides presented to T cells, thus causing the equivalent of an alloreactive T-cell response. Indeed, we identified specific self-peptides that are presented only in the presence of abacavir and that were recognized by T cells of hypersensitive patients. The assays that we have established can be applied to test additional compounds with suspected HLA-linked hypersensitivities in vitro. Where successful, these assays could speed up the discovery and mechanistic understanding of HLA-linked hypersensitivities, and guide the development of safer drugs.
PubMed: 22645359
DOI: 10.1073/pnas.1207934109
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.999 Å)
構造検証レポート
Validation report summary of 3upr
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon